SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (865)12/4/1998 7:17:00 PM
From: David S.  Respond to of 965
 
I ran into the Church Lady last night - (amazing she hangs out where I hang out) and I was just amaaazed at all those little companies working in the TNF area. Such nice little companies. They are soooo...cute.



To: Biomaven who wrote (865)12/8/1998 4:20:00 PM
From: Douglas Babbin  Read Replies (1) | Respond to of 965
 
I spoke w/ someone from investor relations at CNTO today. They attributed the sell off last week to two brokerage firms that lowered the revenue estimates for Remicade. He didn't believe the old Remicade formulation was much of an issue to many investors. In any event, most firms are expecting similar Remicade sales at this point. The other two firms had been overly aggressive.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News